Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy
- 30 June 2011
- journal article
- research article
- Published by Elsevier BV in Sleep Medicine
- Vol. 12 (6), 550-556
- https://doi.org/10.1016/j.sleep.2011.03.010
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepinessJournal of Sleep Research, 2010
- Idiopathic Hypersomnia with and without Long Sleep Time: A Controlled Series of 75 PatientsSleep, 2009
- Practice Parameters for the Treatment of Narcolepsy and other Hypersomnias of Central OriginSleep, 2007
- Idiopathic Hypersomnia: A Study of 77 CasesSleep, 2007
- An update on the pharmacotherapy of excessive daytime sleepiness and cataplexySleep Medicine Reviews, 2004
- CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditionsJournal of Neurology, Neurosurgery & Psychiatry, 2003
- The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other HypersomniasArchives of Neurology, 2002
- Idiopathic HypersomniaSleep Medicine Reviews, 2001
- Modafinil: A Double-Blind Multicentric StudySleep, 1994
- Successful treatment of idiopathic hypersomnia and narcolepsy with modafinilProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988